An exploratory ANOVA was calculated to assess genotype and treatment effects on PARK2 protein concentration in HDF lines taking the duplication and deletion carriers as one group vs. the wildtype ADHD and healthy control as one group to increase statistical power (Figure 2B). This evidence concerns the gene PRKN and attention deficit-hyperactivity disorder.